ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Houston, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Skin Diseases
Immune System Diseases
Eczematous Skin Diseases
Food Hypersensitivity
Genetic Skin Diseases

Eczema trials near Houston, TX, USA:

Assessment of the Effects on the Skin Microbiome of Amending an Over-the-counter Eczema Product With Activated Oil (AO)

This is a single-center, randomized, blinded, controlled trial assessing the effects on the skin microbiome in patients with eczema of amend...

Enrolling
Eczema
Other: topical colloidal oatmeal formulation with a modified plant oil
Other: topical colloidal oatmeal formulation
GlycosBio

Houston, Texas, United States of America

in adults and adolescents with moderate to severe atopic dermatitis (eczema). Eczema is a condition which can cause dryness, itchin...

Enrolling
Atopic Dermatitis
Drug: Tilrekimig
Drug: Dupilumab

Phase 3

Pfizer
Pfizer

Sugar Land, Texas, United States of America and 31 other locations

This is a double-blind, placebo-controlled study where subjects are participating for approximately 36 to 40 weeks. The study compares how well BFB75...

Active, not recruiting
Atopic Dermatitis (AD)
Biological: BFB759
Drug: Placebo

Phase 2

Bluefin Biomedicine, Inc.

Missouri City, Texas, United States and 88 other locations

The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...

Invitation-only
Eczema
Atopic Dermatitis
Drug: Placebo
Drug: Lebrikizumab

Phase 3

Lilly
Lilly

Bellaire, Texas, United States and 95 other locations

This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.

Active, not recruiting
Eczema
Atopic Dermatitis
Drug: ATI-045
Drug: Placebo

Phase 2

Aclaris Therapeutics
Aclaris Therapeutics

Houston, Texas, United States and 60 other locations

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Active, not recruiting
Atopic Dermatitis
Biological: Barzolvolimab
Drug: Matching placebo

Phase 2

Celldex Therapeutics
Celldex Therapeutics

Sugar Land, Texas, United States and 36 other locations

The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...

Active, not recruiting
Atopic Dermatitis
Drug: PF-07275315
Other: Placebo

Phase 2

Pfizer
Pfizer

Houston, Texas, United States and 100 other locations

This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: GHZ339

Phase 2

Novartis
Novartis

Houston, Texas, United States and 110 other locations

(age 12 and older) with moderate-to-severe atopic dermatitis (eczema). Ebglyss is approved by the U.S. Food and Drug Administration, and its...

Begins enrollment this month
Atopic Dermatitis
Biological: Lebrikizumab-lbkz

Phase 4

Forefront Dermatology S.C

Houston, Texas, United States and 9 other locations

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...

Active, not recruiting
Moderate to Severe Atopic Dermatitis
Drug: Rezpegaldesleukin
Drug: Placebo

Phase 2

Nektar Therapeutics
Nektar Therapeutics

Bellaire, Texas, United States and 118 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems